Literature DB >> 25264923

Silencing of CDC42 inhibits neuroblastoma cell proliferation and transformation.

Sora Lee1, Brian T Craig1, Carmelle V Romain1, Jingbo Qiao1, Dai H Chung2.   

Abstract

Cell division cycle 42 (CDC42), a small GTPase of the Rho-subfamily, regulates diverse cellular functions including proliferation, cytoskeletal rearrangement and even promotes malignant transformation. Here, we found that increased expression of CDC42 correlated with undifferentiated neuroblastoma as compared to a more benign phenotype. CDC42 inhibition decreased cell growth and soft agar colony formation, and increased cell death in BE(2)-C and BE(2)-M17 cell lines, but not in SK-N-AS. In addition, silencing of CDC42 decreased expression of N-myc in BE(2)-C and BE(2)-M17 cells. Our findings suggest that CDC42 may play a role in the regulation of aggressive neuroblastoma behavior.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  AKT2; CDC42; N-myc; Neuroblastoma; Transformation; Twist

Mesh:

Substances:

Year:  2014        PMID: 25264923      PMCID: PMC4301604          DOI: 10.1016/j.canlet.2014.08.033

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  28 in total

1.  Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K.

Authors:  P J Keely; J K Westwick; I P Whitehead; C J Der; L V Parise
Journal:  Nature       Date:  1997-12-11       Impact factor: 49.962

2.  Cdc42 regulates anchorage-independent growth and is necessary for Ras transformation.

Authors:  R G Qiu; A Abo; F McCormick; M Symons
Journal:  Mol Cell Biol       Date:  1997-06       Impact factor: 4.272

3.  Characteristics of stem cells from human neuroblastoma cell lines and in tumors.

Authors:  Jeanette D Walton; David R Kattan; Sharon K Thomas; Barbara A Spengler; Hong-Fen Guo; June L Biedler; Nai-Kong V Cheung; Robert A Ross
Journal:  Neoplasia       Date:  2004 Nov-Dec       Impact factor: 5.715

Review 4.  Spontaneous and virus induced transformation in cell culture.

Authors:  J Pontén
Journal:  Virol Monogr       Date:  1971

5.  Inhibition of a new differentiation pathway in neuroblastoma by copy number defects of N-myc, Cdc42, and nm23 genes.

Authors:  Linda J Valentijn; Arjen Koppen; Ronald van Asperen; Heather A Root; Franciska Haneveld; Rogier Versteeg
Journal:  Cancer Res       Date:  2005-04-15       Impact factor: 12.701

6.  Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target.

Authors:  Wai Kei Kwok; Ming-Tat Ling; Tak-Wing Lee; Tracy C M Lau; Chun Zhou; Xiaomeng Zhang; Chee Wai Chua; Kwok W Chan; Franky L Chan; Carlotta Glackin; Yong-Chuan Wong; Xianghong Wang
Journal:  Cancer Res       Date:  2005-06-15       Impact factor: 12.701

7.  Rho family GTPases bind to phosphoinositide kinases.

Authors:  K F Tolias; L C Cantley; C L Carpenter
Journal:  J Biol Chem       Date:  1995-07-28       Impact factor: 5.157

8.  Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells.

Authors:  Sandrine Valsesia-Wittmann; Maud Magdeleine; Sébastien Dupasquier; Elisabeth Garin; Anne-Catherine Jallas; Valérie Combaret; Alexander Krause; Philippe Leissner; Alain Puisieux
Journal:  Cancer Cell       Date:  2004-12       Impact factor: 31.743

9.  Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas.

Authors:  Keith Hoek; David L Rimm; Kenneth R Williams; Hongyu Zhao; Stephan Ariyan; Aiping Lin; Harriet M Kluger; Aaron J Berger; Elaine Cheng; E Sergio Trombetta; Terence Wu; Michio Niinobe; Kazuaki Yoshikawa; Gregory E Hannigan; Ruth Halaban
Journal:  Cancer Res       Date:  2004-08-01       Impact factor: 12.701

10.  Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.

Authors:  Jing Yang; Sendurai A Mani; Joana Liu Donaher; Sridhar Ramaswamy; Raphael A Itzykson; Christophe Come; Pierre Savagner; Inna Gitelman; Andrea Richardson; Robert A Weinberg
Journal:  Cell       Date:  2004-06-25       Impact factor: 41.582

View more
  10 in total

1.  High Expression of Cell Division Cycle 42 Promotes Pancreatic Cancer Growth and Predicts Poor Outcome of Pancreatic Cancer Patients.

Authors:  Dejun Yang; Yu Zhang; Yajun Cheng; Liang Hong; Changming Wang; Ziran Wei; Qingping Cai; Ronglin Yan
Journal:  Dig Dis Sci       Date:  2017-02-08       Impact factor: 3.199

2.  β2-adrenergic receptor drives the metastasis and invasion of pancreatic ductal adenocarcinoma through activating Cdc42 signaling pathway.

Authors:  Chen Gong; Baoying Hu; Haifeng Chen; Jianxin Zhu; Jinshan Nie; Lu Hua; Long Chen; Yanfei Fang; Cheng Hang; Ye Lu
Journal:  J Mol Histol       Date:  2022-06-18       Impact factor: 3.156

3.  Model-based unsupervised learning informs metformin-induced cell-migration inhibition through an AMPK-independent mechanism in breast cancer.

Authors:  Arjun P Athreya; Krishna R Kalari; Junmei Cairns; Alan J Gaglio; Quin F Wills; Nifang Niu; Richard Weinshilboum; Ravishankar K Iyer; Liewei Wang
Journal:  Oncotarget       Date:  2017-04-18

4.  A role for activated Cdc42 in glioblastoma multiforme invasion.

Authors:  Hidehiro Okura; Brian J Golbourn; Uswa Shahzad; Sameer Agnihotri; Nesrin Sabha; Jonathan R Krieger; Carlyn A Figueiredo; Alan Chalil; Natalie Landon-Brace; Alexandra Riemenschneider; Hajime Arai; Christian A Smith; Songli Xu; Stefan Kaluz; Adam I Marcus; Erwin G Van Meir; James T Rutka
Journal:  Oncotarget       Date:  2016-08-30

Review 5.  Regulating Cdc42 and Its Signaling Pathways in Cancer: Small Molecules and MicroRNA as New Treatment Candidates.

Authors:  Xing-Hua Xiao; Lin-Chen Lv; Jing Duan; Ye-Meng Wu; Shu-Jin He; Zhen-Zhen Hu; Li-Xia Xiong
Journal:  Molecules       Date:  2018-03-29       Impact factor: 4.411

6.  Overexpression of CDC42SE1 in A431 Cells Reduced Cell Proliferation by Inhibiting the Akt Pathway.

Authors:  Pazhanichamy Kalailingam; Hui Bing Tan; Jiun Yit Pan; Suat Hoon Tan; Thirumaran Thanabalu
Journal:  Cells       Date:  2019-02-02       Impact factor: 6.600

7.  CHL1 gene acts as a tumor suppressor in human neuroblastoma.

Authors:  Marzia Ognibene; Gabriella Pagnan; Danilo Marimpietri; Davide Cangelosi; Michele Cilli; Maria Chiara Benedetti; Renata Boldrini; Alberto Garaventa; Francesco Frassoni; Alessandra Eva; Luigi Varesio; Vito Pistoia; Annalisa Pezzolo
Journal:  Oncotarget       Date:  2018-05-25

8.  Rho GTPases in A549 and Caco-2 cells dominating the endocytic pathways of nanocarbons with different morphologies.

Authors:  Siyang Song; Hongzhe Fu; Bing He; Dan Wang; Mengmeng Qin; Dan Yang; Dechun Liu; Ge Song; Yujie Shi; Hua Zhang; Xueqing Wang; Wenbing Dai; Qiang Zhang
Journal:  Int J Nanomedicine       Date:  2018-07-27

9.  miR-149 inhibits cell proliferation and enhances chemosensitivity by targeting CDC42 and BCL2 in neuroblastoma.

Authors:  Fengxia Mao; Ju Zhang; Xinru Cheng; Qianya Xu
Journal:  Cancer Cell Int       Date:  2019-12-27       Impact factor: 5.722

10.  The ubiquitin ligase RNF8 regulates Rho GTPases and promotes cytoskeletal changes and motility in triple-negative breast cancer cells.

Authors:  Bruno Pereira De Carvalho; Yi-Jye Chern; Jiabei He; Chia-Hsin Chan
Journal:  FEBS Lett       Date:  2020-12-05       Impact factor: 4.124

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.